Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Drought is over, turn around day

<< Previous

Bullboard Posts

Next >>

Comment by Normandt1965on Apr 21, 2021 9:46am

199 Views

Post# 33036184

RE:RE:RE:RE:RE:RE:RE:RE:Drought is over, turn around day

Come on, stop focusing on the peaks.....check the general progression on 1 year, one year and a half. Look at the chart on 1 year.....steady ramp up. I bought at 0.74 in 2019. Now it's almost 4$ can. Then it's a strong positive progression, not a 50% haircut at all.

<< Previous

Bullboard Posts

Next >>

Globex Mining: Unveiling Québec’s hidden gold and lithium treasures